Non-Hodgkin lymphoma is a common feature of AIDS. Approximately 30-40% of these tumors exhibit clinical features suggestive of endemic Burkitt lymphoma: they are aggressive malignancies that occur in association with Epstein-Barr virus infection, they arise in the setting of immunosuppression, and they carry t(8;14) translocations without detectable rearrangement of the MYC oncogene. To understand the molecular basis of these parallels, we analyzed a case of Epstein-Barr-positive AIDS-associated undifferentiated lymphoma. Southern blots show that the tumor exhibits immuno-
Soon after the first clinical descriptions of AIDS, several reports appeared documenting an increased incidence of Burkitt lymphomas (1, 2) and other non-Hodgkin lymphomas (NHLs) (3) in AIDS patients. Cytogenetic studies of these Burkitt lymphomas demonstrated that they exhibit the same spectrum of chromosome translocations as seen in previously studied Burkitt lymphomas, including the t (8;14) and variant translocations (4) (5) (6) . Approximately 30-40% of these tumors contain the Epstein-Barr virus (EBV) genome (7, 8) . Recently, it has been suggested that the EBV-positive AIDSassociated lymphomas of pleiomorphic histopathology, which carry immunoglobin gene rearrangements but lack detectable MYC oncogene rearrangements, constitute neoplasms of uncertain lineage and distinctly uncommon characteristics that set them apart from most NHLs (9) .
However, several features of the EBV-positive subset of AIDS-associated NHLs led us to speculate that these lymphomas might arise via pathogenic mechanisms similar to those seen in endemic Burkitt lymphomas. Endemic EBVpositive Burkitt lymphomas carry t (8;14) translocations, which exhibit a molecular architecture distinct from the t(8;14)-bearing but EBV-negative sporadic Burkitt lymphomas (10, 11) . The former are thought to arise through the interplay of several environmental and genetic events (12) , including EBV infection and immunosuppression, which together function to expand B-cell populations and enhance the possibility of chromosome translocations and consequent lymphoma (13) . The similarities between this scenario for the genesis of endemic Burkitt lymphoma and the clinical features of AIDSrelated NHLs are striking. Not only do the AIDS-associated tumors carry both EBV genomes and t (8;14) translocations, they are often preceded by expansion of clonal B-cell populations (14) , T-cell regulation of which is abrogated by the immunosuppression of AIDS (15 (18) . The MYC probe (19) and the BCL2 probe (20) have also been described elsewhere. Probes were labeled using 32P by standard nick-translation techniques (21) . Cloning Procedures. Genomic cloning in the phage vector EMBL3 was accomplished by using high-molecular-weight DNA essentially as described (10) . Recombinant clones were mapped by restriction analysis, and selected DNA fragments were then subcloned after electroelution (International Biotechnologies) of restriction-digested DNA from gels. The purified DNA was then ligated into the plasmid pUC 19 or the bacteriophage M13, and transformation of Escherichia coli competent cells was performed as described (11) .
Nucleotide Sequence Analysis. Sequencing was accomplished using the Sanger dideoxynucleotide chain-termination method (22) 
RESULTS
Histopathology. Histopathological examination of stained specimens of the right axillary biopsy demonstrated a diffuse infiltrate that involved the entirety of the node and fat and connective tissue surrounding it. The infiltrate consisted of medium-sized cells with a high nuclear-to-cytoplasmic ratio and intermediate slightly irregular nuclei having somewhat clumped nuclear chromatin without conspicuous nucleoli. The cells were approximately the size of intermixed histiocytes and were relatively uniform throughout the section. These features were interpreted as most consistent with non-Hodgkin lymphoma of undifferentiated (small noncleaved cell) type.
Molecular Analysis of the t(8;14) Translocation. Genomic DNA was extracted from the biopsy tissue (designated FI) obtained from the right axillary lymph node. The DNA was digested with various restriction enzymes for Southern analysis. Rearrangement of the immunoglobulin JH segment was observed using the pHj probe, whereas the MYC and BCL2 genes were both in their germ-line configurations (Fig. 1 ), as were the immunoglobulin A and K loci (data not shown). In addition, a dot-blot experiment probed with an EBV probe confirmed the presence of the EBV genome in the patient's tumor sample (data not shown). 6.6 -2tp 5 6 t' Thus we sought to clone and isolate the breakpoint using a strategy that hinged on the previously demonstrated role of immunoglobulin JH region in endemic Burkitt lymphomas (10) and its hypothesized role in the patient's translocation. That is, lacking a rearrangement of a chromosome 8 probe, the chromosome 14 pHj probe was used for screening.
A recombinant genomic library was constructed in the phage EMBL3 and screened with the pHj probe. Clones were obtained which, when physically mapped, correspond to both JH alleles. Representative clones are illustrated in Fig.  2 . After determining which fragments lack repetitive sequences, a unique 1.9-kilobase (kb) HindIII fragment from H 1. the region 5' of the JH homology was purified and subcloned for use as a probe and was designated H1.9. This probe is identified in Fig. 2 . Because these clones might represent either physiologic immunoglobulin gene rearrangements or translocation breakpoints, it was necessary to show that the H1.9 probe originated from chromosome 8. This probe was hybridized to Southern-blotted DNAs from a panel of somatic cell hybrids containing segregated human chromosomes. Fig. 3 demonstrates that H1.9 hybridizes only to DNA containing the entire chromosome 8. [The filter from Fig. 3 was subsequently stripped and hybridized to the pRYC7.4 MYC probe; the hybridization pattern obtained (data not shown) is identical to that obtained using H1.9, further demonstrating synteny of pH1.9 and MYC.] We next sought to determine whether the region of the genome including the H1.9 probe is amplified in the COLO 320 cell line, which carries an amplification unit that encompasses regions surrounding MYC (23). Previous work had shown that the p380j9 probe, which is localized near the chromosome 8 translocation breakpoints of several endemic Burkitt lymphomas (10, 11) , is included in the COLO 320 amplification unit (F.H., unpublished results). Fig. 4 illustrates that H1.9 is, indeed, amplified in COLO 320. These lines ofevidence show that H1.9 contains chromosome 8 sequences that lie some undetermined distance from MYC (as in endemic Burkitt lymphomas) and that, therefore, the phage clones, indeed, include the t (8;14) junction.
Nucleotide Sequence Analysis. To examine the structure of the translocated breakpoint, the nucleotide sequence across the chromosome junction was obtained. A portion of the sequence is shown in Fig. 5 . It was found that the breakpoint lies 7 nucleotides from the previously described cell line P3HR-1 endemic Burkitt lymphoma breakpoint, upstream of the J5 segment (10) . Thus, at the molecular level this translocation is nearly identical to a previously analyzed translocation carried by an endemic, EBV-positive Burkitt lymphoma.
DISCUSSION
It is well recognized that aggressive NHLs occur in AIDS patients, accounting for from between 2.5% and 5% of primary AIDS diagnoses in a recent series (8 Recent work from other laboratories reported that, in some cases of AIDS patients with NHLs, MYC and immunoglobulin gene rearrangements characteristic of the sporadic form of Burkitt lymphoma were present (7). Furthermore, some tumors were EBV negative and were heterogeneous with respect to MYC rearrangements. It appears that, as in endemic and sporadic Burkitt lymphomas, the molecular characteristics of the translocations correlate with the presence of the EBV genome. The same group also described NHLs in AIDS patients to be heterogeneous with respect to the histopathology and to be EBV positive (9) . We suggest that these EBV-positive NHLs will also display molecular architecture similar to that seen in the case studied here.
The data that we present support our contention that such EBV-positive tumors, like endemic Burkitt lymphoma, may carry translocations that activate the MYC oncogene, the direct consequence of which is lymphomagenesis. EBV probably functions as an environmental cofactor that enhances the probability for translocation. The translocation analyzed here, from an AIDS patient with an undifferentiated NHL, exhibits several molecular similarities to the translocations analyzed from endemic Burkitt lymphomas. The region immediately surrounding MYC is not rearranged by Southern blot. Yet regions far 5' of MYC on chromosome 8 are involved. This is the general case for endemic Burkitt lymphomas, as has been shown by our laboratory (10, 11) and others (24) . Thus, with regard to the chromosome 8 breakpoint localization, this case fits the pattern established by analysis of endemic Burkitt lymphoma translocation breakpoints.
On chromosome 14, the analogy is also substantiated. The translocation junction is 7 base pairs from the previously characterized P3HR-1 endemic Burkitt lymphoma breakpoint. The breakpoint lies within the JH regions, upstream of J5. A conserved signal sequence homologous to the immunoglobulin recombinase heptamer-nonamer (25) is also present. Upstream of the breakpoint on chromosome 14 is a heptamer that matches the functional recombination signal actually used by J5 at 5 of 7 positions: CAATGCC is near the break, whereas CAATGTG is seen at J5. Farther upstream, 23 base pairs from the heptamer, is a nonamer previously described for P3HR-1 endemic Burkitt lymphoma. In sum, the molecular features of the t(8;14) translocation in this AIDS-associated NHL are strongly reminiscent of those of the endemic Burkitt lymphoma cases.
The relationship between the epidemiology and the molecular genetics of Burkitt lymphoma is now quite well understood. Burkitt lymphomas occur in two distributions throughout the world. The endemic form occurs primarily in equatorial Africa, where it is associated in over 97% of cases with EBV infection (12) . The sporadic form, in contrast, is found largely in Europe and North America and is associated with EBV in -20% of cases. (10) , which catalyze physiologic recombination at the immunoglobulin and T-cell receptor loci in early lymphocytes (25) . MYC rearrangements are not detectable in these latter tumors. Thus a strong correlation exists between the type of Burkitt lymphoma (endemic versus sporadic), the structure of the translocated chromosome, and the point during lymphocyte differentiation (pre-B-cell V-D-J joining versus mature B-cell isotype switching) at which the translocation occurs.
This correlation has several consequences for current thinking regarding the pathogenesis of these tumors. Crucial to this discussion is the role of EBV (12) . EBV can immortalize B cells and is routinely used in vitro to establish lymphoblastoid cell lines. In vivo it engenders polyclonal B-cell activation, which is subject to T-cell regulation. Taking these findings into account, the hypothetical scenario for the pathogenesis of endemic Burkitt lymphoma is as follows. In endemic regions, infection of a young individual occurs without clinical disease. However, if the EBV-infected individual contracts malaria, immunosuppression ensues. Polyclonal B lymphocyte proliferation proceeds unchecked in the absence of T-cell suppression, probably enlarging the population of B cells subject to genetic change. This enhances the probability of recombinase error, which may ultimately lead to translocation and lymphomagenesis.
In AIDS-associated, EBV-positive NHL cases, such as the one described here, the parallel with the pathogenesis of endemic cases is evident. EBV infection and profound immunosuppression facilitate abnormal B-lymphocyte proliferation. The lack of normal regulation of the immune response to EBV has been studied directly in AIDS patients (15) ; T-cell suppression of EBV-induced B-cell proliferation is totally absent in these patients. The resultant polyclonal B-cell expansion is easily detected in patients with the lymphadenopathy syndrome, as well as with AIDS (14) . This pool of B cells is the substrate for recombinase error during immunoglobulin rearrangement, just as in endemic cases.
This -case also underscores the fact that several types of malignancies have been shown to carry t(8;14) translocations. These genetic lesions have now been described in Burkitt lymphoma, AIDS-associated NHL, acute lymphoblastic leukemia, and in follicular lymphomas that evolve into acute leukemia (26) . Thus, a variety of lymphoid neoplasms may share common molecular mechanisms of lymphomagenesis. In particular, AIDS-associated NHLs such as the case described here may prove to carry remarkably uniform genetic alterations.
